PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer
Clinical trial NCT05659186 · UNKNOWN
Trial details
- NCT number
- NCT05659186
- Sponsor
- West China Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-30
- Primary completion
- 2024-12-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.